- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01429103
Hormones and Cognition in the Menopausal Transition
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Clinical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Menopausal status will be based on self-report of menstrual cycles over the past 12 months. Early perimenopause is defined as the presence of irregular periods (cycle length differs by 7 days from usual). Late perimenopause is defined as at least 2 skipped periods over the past 12 months (cycle double usual length) and one period of amenorrhea (over 60 days without a period), with at least one menstrual cycle over the past 12 months, according to the Stages of Reproductive Aging Workshop criteria.
Exclusion Criteria:
- history of neurological disease known to affect cognitive function (i.e., stroke, MS, etc) and major psychiatric illness. The investigators will exclude women who are currently pregnant or breast-feeding, have undergone surgical menopause, or who have used exogenous hormone preparations affecting ovarian or pituitary function in the past 3 months. The investigators will also exclude women who have had hysterectomies, but intact ovaries, or oophorectomies. Women who choose to initiate HRT at some point during the study will continue to be followed, but their data obtained after HRT is initiated will be analyzed separately.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Early Perimenopause
Early perimenopause is defined as the presence of irregular periods (cycle length differs by 7 days from usual).
|
Late Perimenopause
Late perimenopause is defined as at least 2 skipped periods over the past 12 months (cycle double usual length) and one period of amenorrhea (over 60 days without a period), with at least one menstrual cycle over the past 12 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Miriam Weber, PhD, Department of Neurology, University of Rochester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Weber K23
- 1K23AG034256 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alteration of Cognitive Function
-
National Taiwan University HospitalCompletedAlteration of Cognitive FunctionTaiwan
-
Northumbria UniversityCompletedAlteration of Cognitive FunctionUnited Kingdom
-
University of FloridaCompletedAlteration of Cognitive Function
-
Ajou University School of MedicineCompletedDietary Modification | Alteration of Cognitive Function
-
Johns Hopkins UniversityCompleted
-
University of Dublin, Trinity CollegeActial Farmaceutica S.r.l.UnknownAlteration of Cognitive Function | Disturbance in Affect (Finding)Ireland
-
University of FloridaCompletedAgeing | Alteration of Cognitive FunctionUnited States
-
Ufuk UniversityCompletedGastrointestinal Dysfunction | Alteration of Cognitive Function
-
Universidad Complutense de MadridMinisterio de Economía y Competitividad, SpainCompletedDepression | Cognitive Deficits | Alteration of Cognitive FunctionSpain
-
University Hospital, LilleUnknownHypoxia | Alteration of Cognitive FunctionFrance